6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Host factors associated with either VP16 or VP16‐induced complex differentially affect HSV‐1 lytic infection

      review-article
      1 , 2 , , 1 , 3 , 4 ,
      Reviews in Medical Virology
      John Wiley and Sons Inc.
      HSV‐1, IE, latency, VP16, VP16‐induced complex

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Herpes simplex virus type 1 (HSV‐1) is an important human pathogen with neurotropism. Following lytic infection in mucosal or skin epithelium, life‐long latency is established mainly in sensory neurons, which can periodically reactivate by stress, leading to recurrent disease and virus transmission. During the virus's productive infection, the tegument protein VP16, a component of HSV‐1 virion, is physically associated with two cellular factors, host cell factor‐1 (HCF‐1), and POU domain protein Oct‐1, to construct the VP16‐induced complex, which is essential to stimulate immediate early (IE)‐gene transcription as well as initiate the lytic programme. Apart from HCF‐1 and Oct‐1, VP16 also associates with a series of other host factors, making a VP16‐induced regulatory switch to either activate or inactivate virus gene transcription. In addition, VP16 has effects on distinct signalling pathways via binding to various host molecules that are essentially related to innate immune responses, RNA polymerases, molecular chaperones, and virus infection‐induced host shutoff. VP16 also functionally compensates for given host factors, such as PPAR‐γ and ß‐catenin. In this review, we provide an overview of the updated insights on the interplay between VP16 and the host factors that coordinate virus infection.

          Related collections

          Most cited references132

          • Record: found
          • Abstract: found
          • Article: not found

          Peroxisomes are signaling platforms for antiviral innate immunity.

          Peroxisomes have long been established to play a central role in regulating various metabolic activities in mammalian cells. These organelles act in concert with mitochondria to control the metabolism of lipids and reactive oxygen species. However, while mitochondria have emerged as an important site of antiviral signal transduction, a role for peroxisomes in immune defense is unknown. Here, we report that the RIG-I-like receptor (RLR) adaptor protein MAVS is located on peroxisomes and mitochondria. We find that peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. The interferon regulatory factor IRF1 plays a crucial role in regulating MAVS-dependent signaling from peroxisomes. These results establish that peroxisomes are an important site of antiviral signal transduction. Copyright (c) 2010 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012

            Background Herpes simplex virus type 1 (HSV-1) commonly causes orolabial ulcers, while HSV-2 commonly causes genital ulcers. However, HSV-1 is an increasing cause of genital infection. Previously, the World Health Organization estimated the global burden of HSV-2 for 2003 and for 2012. The global burden of HSV-1 has not been estimated. Methods We fitted a constant-incidence model to pooled HSV-1 prevalence data from literature searches for 6 World Health Organization regions and used 2012 population data to derive global numbers of 0-49-year-olds with prevalent and incident HSV-1 infection. To estimate genital HSV-1, we applied values for the proportion of incident infections that are genital. Findings We estimated that 3709 million people (range: 3440–3878 million) aged 0–49 years had prevalent HSV-1 infection in 2012 (67%), with highest prevalence in Africa, South-East Asia and Western Pacific. Assuming 50% of incident infections among 15-49-year-olds are genital, an estimated 140 million (range: 67–212 million) people had prevalent genital HSV-1 infection, most of which occurred in the Americas, Europe and Western Pacific. Conclusions The global burden of HSV-1 infection is huge. Genital HSV-1 burden can be substantial but varies widely by region. Future control efforts, including development of HSV vaccines, should consider the epidemiology of HSV-1 in addition to HSV-2, and especially the relative contribution of HSV-1 to genital infection.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

              RIG-I is a key mediator of antiviral immunity, able to couple detection of infection by RNA viruses to the induction of interferons. Natural RIG-I stimulatory RNAs have variously been proposed to correspond to virus genomes, virus replication intermediates, viral transcripts, or self-RNA cleaved by RNase L. However, the relative contribution of each of these RNA species to RIG-I activation and interferon induction in virus-infected cells is not known. Here, we use three approaches to identify physiological RIG-I agonists in cells infected with influenza A virus or Sendai virus. We show that RIG-I agonists are exclusively generated by the process of virus replication and correspond to full-length virus genomes. Therefore, nongenomic viral transcripts, short replication intermediates, and cleaved self-RNA do not contribute substantially to interferon induction in cells infected with these negative strand RNA viruses. Rather, single-stranded RNA viral genomes bearing 5'-triphosphates constitute the natural RIG-I agonists that trigger cell-intrinsic innate immune responses during infection. 2010 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                dneumann3@wisc.edu
                lzhu3596@163.com
                Journal
                Rev Med Virol
                Rev Med Virol
                10.1002/(ISSN)1099-1654
                RMV
                Reviews in Medical Virology
                John Wiley and Sons Inc. (Hoboken )
                1052-9276
                1099-1654
                07 September 2022
                November 2022
                : 32
                : 6 ( doiID: 10.1002/rmv.v32.6 )
                : e2394
                Affiliations
                [ 1 ] Institute of Life Science and Green Development School of Life Science Hebei University Baoding China
                [ 2 ] Department of Ophthalmology and Visual Sciences University of Wisconsin‐Madison Madison Wisconsin USA
                [ 3 ] College of Veterinary Medicine Yangzhou University Yangzhou China
                [ 4 ] Key Laboratory of Microbial Diversity Research and Application of Hebei Province College of Life Science Hebei University Baoding China
                Author notes
                [*] [* ] Correspondence

                Donna M. Neumann, Department of Ophthalmology and Visual Sciences, University of Wisconsin‐Madison, Madison, WI, USA.

                Email: dneumann3@ 123456wisc.edu

                Liqian Zhu, Institute of Life Science and Green Development, School of Life Science, Hebei University, Baoding 071002, China.

                Email: lzhu3596@ 123456163.com

                Author information
                https://orcid.org/0000-0002-9579-2252
                Article
                RMV2394
                10.1002/rmv.2394
                9786836
                36069169
                df33757e-9f30-48cd-9c90-d8112ca98c35
                © 2022 The Authors. Reviews in Medical Virology published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 15 July 2022
                : 07 May 2022
                : 25 August 2022
                Page count
                Figures: 1, Tables: 0, Pages: 10, Words: 8809
                Funding
                Funded by: High‐level Talents Research Start‐up Project of Hebei University
                Funded by: Unrestricted Grant from Research to Prevent Blindness, Inc. to the UW‐Madison Department of Ophthalmology and Visual Sciences
                Funded by: National Natural Science Foundation of China , doi 10.13039/501100001809;
                Funded by: NIH‐NIAID
                Categories
                Review
                Reviews
                Custom metadata
                2.0
                November 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.3 mode:remove_FC converted:23.12.2022

                Microbiology & Virology
                hsv‐1,ie,latency,vp16,vp16‐induced complex
                Microbiology & Virology
                hsv‐1, ie, latency, vp16, vp16‐induced complex

                Comments

                Comment on this article